Hologic ATEC Breast Biopsy and Excision System - HSA Registration DE0011651
Access comprehensive regulatory information for Hologic ATEC Breast Biopsy and Excision System in the Singapore medical device market through Pure Global AI's free database. This CLASS B medical device is registered under HSA registration number DE0011651 and owned by Hologic, Inc. The device was registered on November 22, 2012.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The ATEC Breast Biopsy and Excision System is indicated to provide breast tissue samples for diagnostic sampling of breast abnormalities. The ATEC Breast Biopsy and Excision System is intended to provide breast tissue for histologic examination with partial or complete removal of the imaged abnormality. The extent of the histologic abnormality cannot be reliably determined from its mammographic appearance. Therefore, the extent of the removal of the imaged evidence of an abnormality does not predict the extent of removal of histologic abnormality e.g. malignancy. When the sampled abnormality is not histologically benign, it is essential that the tissue margins be examined for completeness of removal using standard surgical procedure.

